Gossamer Bio GOSS
NASDAQ GOSS
$0.16 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Revenue (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly Revenue of $17.0 million for Q1 2026, up 71.45% year-over-year from $9.9 million in Q1 2025, and up 22.87% quarter-over-quarter from $13.8 million in Q4 2025.

Gossamer Bio (GOSS) Revenue (2024 - 2026) Analysis & Trends

Gossamer Bio's Revenue history runs 3 years deep, the most recent figure standing at $17.0 million for Q1 2026.

  • In Q1 2026, Revenue rose 71.45% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $55.5 million (down 44.79% YoY), while the FY2025 annual figure was $48.5 million, down 46.56% from the prior year.
  • Revenue for Q1 2026 stood at $17.0 million, up from $13.8 million in the prior quarter.
  • The five-year high for Revenue was $95.8 million in Q2 2024, with the low at -$14.6 million in Q4 2024.
  • The 3-year median for Revenue is $12.4 million (2025), against an average of $19.5 million.
  • Peak annual rise in Revenue reached 194.37% in 2025, while the deepest fall reached 88.01% in 2025.
  • Gossamer Bio's Revenue stood at -$14.6 million in 2024, then surged by 194.37% to $13.8 million in 2025, then rose by 22.87% to $17.0 million in 2026.
  • Business Quant data shows GOSS's Revenue at $17.0 million in Q1 2026, $13.8 million in Q4 2025, and $13.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Gossamer Bio 50.34 Mn -6.69 Mn - 9.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.24 Mn
Mar 31, 2026 16.96 Mn
Dec 31, 2025 13.80 Mn
Sep 30, 2025 13.29 Mn
Jun 30, 2025 11.49 Mn
Mar 31, 2025 9.89 Mn
Dec 31, 2024 -14.62 Mn
Sep 30, 2024 9.48 Mn
Jun 30, 2024 95.84 Mn